Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5O7N

Beta-lactamase VIM-2 in complex with (2R)-1-(2-Benzyl-3-mercaptopropanoyl)piperidine-2-carboxylic acid

5O7N の概要
エントリーDOI10.2210/pdb5o7n/pdb
分子名称Beta-lactamase VIM-2, ZINC ION, (2~{R})-1-[(2~{S})-2-(phenylmethyl)-3-sulfanyl-propanoyl]piperidine-2-carboxylic acid, ... (6 entities in total)
機能のキーワードinhibitor, complex, mbl, beta-lactamase vim-2, (2r)-1-(2-benzyl-3-mercaptopropanoyl)piperidine-2-carboxylic acid, hydrolase
由来する生物種Klebsiella pneumoniae
タンパク質・核酸の鎖数2
化学式量合計56333.03
構造登録者
Buettner, D.,Kramer, J.S.,Pogoryelov, D.,Proschak, E. (登録日: 2017-06-09, 公開日: 2018-06-20, 最終更新日: 2024-05-08)
主引用文献Buttner, D.,Kramer, J.S.,Klingler, F.M.,Wittmann, S.K.,Hartmann, M.R.,Kurz, C.G.,Kohnhauser, D.,Weizel, L.,Bruggerhoff, A.,Frank, D.,Steinhilber, D.,Wichelhaus, T.A.,Pogoryelov, D.,Proschak, E.
Challenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-beta-Lactamases.
Acs Infect Dis., 4:360-372, 2018
Cited by
PubMed Abstract: Pathogens, expressing metallo-β-lactamases (MBLs), become resistant against most β-lactam antibiotics. Besides the dragging search for new antibiotics, development of MBL inhibitors would be an alternative weapon against resistant bacterial pathogens. Inhibition of resistance enzymes could restore the antibacterial activity of β-lactams. Various approaches to MBL inhibitors are described; among others, the promising motif of a zinc coordinating thiol moiety is very popular. Nevertheless, since the first report of a thiol-based MBL inhibitor (thiomandelic acid) in 2001, no steps in development of thiol based MBL inhibitors were reported that go beyond clinical isolate testing. In this study, we report on the synthesis and biochemical characterization of thiol-based MBL inhibitors and highlight the challenges behind the development of thiol-based compounds, which exhibit good in vitro activity toward a broad spectrum of MBLs, selectivity against human off-targets, and reasonable activity against clinical isolates.
PubMed: 29172434
DOI: 10.1021/acsinfecdis.7b00129
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.5 Å)
構造検証レポート
Validation report summary of 5o7n
検証レポート(詳細版)ダウンロードをダウンロード

247536

件を2026-01-14に公開中

PDB statisticsPDBj update infoContact PDBjnumon